irf4 addiction multiple myeloma 
transcription factor irf4 interferon regulatory factor required immune response lymphocyte activation generation immunoglobulin secreting plasma cells1- multiple myeloma malignancy plasma cells complex molecular aetiology several subgroups defined gene expression profiling recurrent chromosomal translocations45 moreover malignant clone can sustain multiple oncogenic lesions accumulating genetic damage disease progresses67 current therapies myeloma can extend survival curative89 hence new therapeutic strategies needed target molecular pathways shared subtypes myeloma show using loss function rna interference based genetic screen irf4 inhibition toxic myeloma cell lines regardless transforming oncogenic mechanism gene expression profiling genome wide chromatin immunoprecipitation analysis uncovered extensive network irf4 target genes identified myc direct target irf4 activated b cells myeloma unexpectedly irf4 direct target myc transactivation generating autoregulatory circuit myeloma cells although irf4 genetically altered myelomas nonetheless addicted aberrant irf4 regulatory network fuses gene expression programmes normal plasma cells activated b cells 
